You are here

  • Home
  • Archive
  • Volume 80, Issue 3
  • Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

Article metrics

Article menu
Download PDFPDF
Sjögren’s syndrome
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 20202977204139
Dec 202012028156
Jan 20214203618
Feb 20211614195104
Mar 20212891171105
Apr 20217106737
May 20212244632
Jun 2021594424
Jul 2021452718
Aug 202135189
Sep 2021332318
Oct 202111932321
Nov 20214292313
Dec 20213122914
Jan 20222813420
Feb 20223391921
Mar 20222562315
Apr 2022205156
May 20223651128
Jun 20223732619
Jul 20222912716
Aug 20222352712
Sep 20222971813
Oct 20224723823
Nov 20222521911
Dec 20221621810
Jan 2023189197
Feb 20234391910
Mar 20233453021
Apr 20232232512
May 20232623214
Jun 20232362014
Jul 20232391912
Aug 2023223209
Sep 20232583315
Oct 20232403218
Nov 20233993015
Dec 20233091910
Jan 20243752717
Feb 20243993330
Mar 20242392710
Total2004716471016